RxDoctor Payments Data

Anita Wokhlu, MD

Cardiovascular Disease · Gainesville, FLNPI 1134131774

Payments from drug & device makers

$121,162in general payments, 2019–2025

Across 75 payments — averaging $1615.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$61K
  • AbbVie$59K
  • Novartis$1K
  • Abbott$91

What the payments were for

  • Food & beverage$91100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer43$60,667
AbbVie29$59,368
Novartis1$1,037
Abbott2$91

How this compares

$121,162 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$28,162
Medicare patients
267
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →